EP 3129059 A1 20170215 - NOVEL COMBINATION BETWEEN 8-CYCLOPROPYL-3-[2-(3-FLUOROPHENYL) ETHYL]-7,8-DIHYDRO-3H-[1,3]OXAZINO[6,5-G][1,2,3]BENZOTRIAZINE-4,9-DIONEAND AN ACETYLCHOLINESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Title (en)
NOVEL COMBINATION BETWEEN 8-CYCLOPROPYL-3-[2-(3-FLUOROPHENYL) ETHYL]-7,8-DIHYDRO-3H-[1,3]OXAZINO[6,5-G][1,2,3]BENZOTRIAZINE-4,9-DIONEAND AN ACETYLCHOLINESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Title (de)
NEUARTIGE KOMBINATION ZWISCHEN 8-CYCLOPROPYL-3-[2-(3-FLUORPHENYL)ETHYL]-7,8-DIHYDRO-3H-[1,3]OXAZINO[6,5-G][1,2,3]BENZOTRIAZIN-4,9-DION UND ACETYLCHOLINESTERASE-INHIBITOREN SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAMIT
Title (fr)
NOUVELLE ASSOCIATION ENTRE LE 8-CYCLOPROPYL-3-[2-(3-FLUOROPHENYL) ETHYL]-7,8-DIHYDRO-3H-[1,3]OXAZINO[6,5-G][1,2,3]BENZOTRIAZINE-4,9-DIONE ET UN INHIBITEUR DE L'ACETYLCHOLINESTERASE, ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CELLE-CI
Publication
Application
Priority
- FR 1453046 A 20140407
- FR 2015050879 W 20150403
Abstract (en)
[origin: WO2015155451A1] Combination between 8-cyclopropyl-3-[2-(3-fluorophenyl)ethyl]-7,8- dihydro-3H-[l,3] oxazino[6,5-g][l,2,3]benzotriazine-4,9-dione of formula (I) or an addition salt thereof with a pharmaceutically acceptable acid or base, and an acetylcholinesterase inhibitor.
IPC 8 full level
A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 31/27 (2006.01); A61K 31/445 (2006.01); A61K 31/5365 (2006.01); A61K 31/55 (2006.01); A61P 25/28 (2006.01)
CPC (source: CN EP KR US)
A61K 9/2013 (2013.01 - EP KR US); A61K 9/2018 (2013.01 - EP KR US); A61K 9/2054 (2013.01 - US); A61K 9/2059 (2013.01 - CN EP KR US); A61K 31/27 (2013.01 - CN EP KR US); A61K 31/445 (2013.01 - CN EP KR US); A61K 31/5365 (2013.01 - CN EP KR US); A61K 31/55 (2013.01 - CN EP KR US); A61K 45/06 (2013.01 - CN EP KR US); A61P 25/00 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 43/00 (2017.12 - EP); A61K 2300/00 (2013.01 - KR)
Citation (search report)
See references of WO 2015155451A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
FR 3019464 A1 20151009; FR 3019464 B1 20160506; AU 2015245416 A1 20161027; CA 2944750 A1 20151015; CL 2016002518 A1 20170317; CN 106163563 A 20161123; EA 201692006 A1 20170228; EP 3129059 A1 20170215; JP 2017510597 A 20170413; KR 20160134854 A 20161123; MA 39493 A 20151015; MD 20160115 A2 20170228; MX 2016013118 A 20170120; PE 20170332 A1 20170415; PH 12016501982 A1 20170109; RU 2016143382 A 20180507; SG 11201608152R A 20161129; US 2017027949 A1 20170202; WO 2015155451 A1 20151015; ZA 201606873 B 20181128
DOCDB simple family (application)
FR 1453046 A 20140407; AU 2015245416 A 20150403; CA 2944750 A 20150403; CL 2016002518 A 20161004; CN 201580018480 A 20150403; EA 201692006 A 20150403; EP 15719502 A 20150403; FR 2015050879 W 20150403; JP 2016561308 A 20150403; KR 20167030840 A 20150403; MA 39493 A 20150403; MD 20160115 A 20150403; MX 2016013118 A 20150403; PE 2016001884 A 20150403; PH 12016501982 A 20161005; RU 2016143382 A 20150403; SG 11201608152R A 20150403; US 201515302245 A 20150403; ZA 201606873 A 20161006